CA Patent

CA2379152A1 — Novel angiopoietin materials and methods

Assigned to Nuvelo Inc · Expires 2001-01-25 · 25y expired

What this patent protects

The present invention provides novel nucleic acids encoding human angiopoietins, the novel polypeptides encoded by these nucleic acids and use s of these and related products.

USPTO Abstract

The present invention provides novel nucleic acids encoding human angiopoietins, the novel polypeptides encoded by these nucleic acids and use s of these and related products.

Drugs covered by this patent

Patent Metadata

Patent number
CA2379152A1
Jurisdiction
CA
Classification
—
Expires
2001-01-25
Drug substance claim
No
Drug product claim
No
Assignee
Nuvelo Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.